+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enzymes Market Research Reports

From
Pim Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Pim Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Monoamine Oxidase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Monoamine Oxidase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
5-Alpha Reductase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

5-Alpha Reductase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Receptor Tyrosine Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Receptor Tyrosine Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
SRC Family Kinases (SFK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

SRC Family Kinases (SFK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Alpha Glucosidase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha Glucosidase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Xanthine Oxidase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Xanthine Oxidase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
cFMS Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

cFMS Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Viral RNA Polymerase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Viral RNA Polymerase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Enzymes market is a sector of the biotechnology industry that produces enzymes for use in a variety of applications. Enzymes are proteins that act as catalysts in biochemical reactions, speeding up the rate of reaction and allowing for more efficient production of products. Enzymes are used in a variety of industries, including food and beverage, pharmaceuticals, detergents, and biofuels. The Enzymes market is highly competitive, with a number of large companies competing for market share. Some of the major players in the market include Novozymes, DuPont, DSM, and BASF. These companies are engaged in research and development of new enzymes, as well as the production and marketing of existing enzymes. They also provide technical support and services to customers. Smaller companies are also active in the market, providing specialized enzymes for niche applications. Show Less Read more